Frequently Asked Questions

Get answers to common questions about Tirzepatide (Monjurno/ Zepbound).

Tirzepatide decreases appetite and slows gastric emptying, helping you feel full sooner and longer. This reduces caloric intake and supports weight loss when paired with diet and activity. We evaluate medical suitability and personalize dosing for safe, effective results.

Tirzepatide is administered as a microdosed injection once weekly. Monthly supply typically includes four injections. Initial titration may be used; we provide in-office or virtual training and regular follow-up to monitor response and adjust dose as needed.

Common side effects include nausea, diarrhea, constipation, and early satiety. These tend to be dose-related and improve with gradual titration. Report severe or persistent symptoms, abdominal pain, or signs of pancreatitis; we offer strategies to manage side effects.

Yes. We offer virtual appointments for evaluation, prescription, and follow-up while in-office visits are available for injections or initial assessment when needed. We ship or provide pick-up options and teach safe self-administration during virtual or in-person training sessions.

The monthly cost is $635 for four injections. Additional fees for consultations, labs, or follow-up may apply. Insurance coverage varies and often does not cover this medication; ask about membership, promotions, or financing options during your consultation.

Adults with overweight or obesity who want medically supervised weight loss may be candidates. We assess medical history, medications, pregnancy plans, and contraindications like personal history of medullary thyroid carcinoma. A comprehensive evaluation determines if tirzepatide is appropriate.